Showing 1,041 - 1,060 results of 1,266 for search '"Lung cancer"', query time: 0.08s Refine Results
  1. 1041

    Integrating Knowledge Graphs with Symbolic AI: The Path to Interpretable Hybrid AI Systems in Medicine by Maria-Esther Vidal, Yashrajsinh Chudasama, Hao Huang, Disha Purohit, Maria Torrente

    Published 2025-01-01
    “…This position paper examines the challenges and research opportunities in integrating KGs with neuro-symbolic AI, highlighting their potential to enhance explainability, scalability, and context-aware reasoning in hybrid AI systems. Using a lung cancer use case, we illustrate how hybrid approaches address tasks such as link prediction—uncovering hidden relationships in medical data—and counterfactual reasoning—analyzing alternative scenarios to understand causal factors. …”
    Get full text
    Article
  2. 1042

    Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A... by Yoshitaka Saito, Yoh Takekuma, Hajime Asahina, Ryo Hisada, Mitsuru Sugawara

    Published 2024-01-01
    “…Here, we report a case of significantly delayed rheumatic irAEs (Rh-irAEs) with prior possible temporary neutropenic irAEs in a patient with atezolizumab-treated non-small-cell lung cancer and its management. A man in his sixties received atezolizumab monotherapy as the sixth-line treatment. …”
    Get full text
    Article
  3. 1043

    Triple-drug antibiotic therapy for disseminated nocardial abscess in the mediastinum and brain of an immunocompetent patient: a case report by Yue Zhang, Zhongchun Qi, Hua Li, Hui Gao

    Published 2025-01-01
    “…Conclusions Mediastinal nocardiosis with disseminated brain abscesses is a rare condition that can be difficult to differentiate from brain metastases caused by lung cancer. Bacterial culture results, imaging features, and MDT discussions are crucial for accurate diagnosis and treatment. …”
    Get full text
    Article
  4. 1044

    Asbestos Induces Reduction of Tumor Immunity by Naoko Kumagai-Takei, Megumi Maeda, Ying Chen, Hidenori Matsuzaki, Suni Lee, Yasumitsu Nishimura, Junichi Hiratsuka, Takemi Otsuki

    Published 2011-01-01
    “…Asbestos-related cancers such as malignant mesothelioma and lung cancer are an important issue in the world. There are many conflicts concerning economical considerations and medical evidence for these cancers and much confusion regarding details of the pathological mechanisms of asbestos-induced cancers. …”
    Get full text
    Article
  5. 1045

    The Use of Porous Scaffold as a Tumor Model by Mei Zhang, Philip Boughton, Barbara Rose, C. Soon Lee, Angela M. Hong

    Published 2013-01-01
    “…High-density low-volume seeding was used to promote attachment of a non-small-cell lung cancer cell line (NCI-H460) to scaffolds. Growth patterns in 3D culture were compared with those of monolayers. …”
    Get full text
    Article
  6. 1046
  7. 1047

    Canine lung carcinoma—A descriptive review by Aleksandra Marcinowska, Aleksandra Marcinowska, Rodrigo Dos Santos Horta, Felisbina Queiroga, Felisbina Queiroga, Antonio Giuliano, Antonio Giuliano, Antonio Giuliano

    Published 2025-01-01
    “…Primary lung cancer is a relatively uncommon tumor in dogs, accounting for about 1% of all canine malignancies. …”
    Get full text
    Article
  8. 1048

    Image Characterization of Cancer of the Colon by Thaimi Conde Cueto, Martha Yudey Rodríguez Pino, Pedro Juan Barrios Fuentes, Bárbara Aleida García Hernández, Julio Suz Piña, Nery M. Díaz Yanes

    Published 2011-04-01
    “…<strong>Background:</strong> Cancer of the colon is the second cause of death due to cancer worldwide, alter lung cancer in males and breast cancer in females. It is not possible to confirm the patient’s diagnosis without the result of image tests such as barium enema, ultrasound cytology or biopsy of the lesion. …”
    Get full text
    Article
  9. 1049

    Feasibility of Using High-Resolution Computed Tomography Features for Invasiveness Differentiation of Malignant Nodules Manifesting as Ground-Glass Nodules by Xinyue Chen, Benbo Yao, Juan Li, Chunxiao Liang, Rui Qi, Jianqun Yu

    Published 2022-01-01
    “…Ground-glass nodule (GGN)-like adenocarcinoma is a special subtype of lung cancer. The invasiveness of the nodule correlates well with the patient’s prognosis. …”
    Get full text
    Article
  10. 1050

    Receptor Status Differences in Prognosis for Breast Cancer by Yelda Deligöz Bildacı, Deniz Yamaç, Uğur Coşkun

    Published 2024-07-01
    “…It is the most common cancer type in the world after lung cancer. The prognosis of the disease mostly depends on the type and stage of cancer. …”
    Get full text
    Article
  11. 1051

    p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis. by Özgün Le Roux, Jeffery I Everitt, Christopher M Counter

    Published 2024-01-01
    “…Loss of the Trp53 gene encoding the tumor suppressor p53 enhances the ability of oncogenic Kras to initiate tumorigenesis in carcinogen and genetic models of lung cancer. Conversley, an extra copy of Trp53 (Super p53) was recently shown to suppress Kras-induced tumorigenesis in a genetic model of this disease. …”
    Get full text
    Article
  12. 1052

    Implications of the Incidental Finding of a MYCN Amplified Adrenal Tumor: A Case Report and Update of a Pediatric Disease Diagnosed in Adults by Anna Koumarianou, Panagiota Oikonomopoulou, Margarita Baka, Dimitrios Vlachodimitropoulos, Stylianos Argentos, Theodoros Piperos, Maria-Ioanna Christodoulou, Kakoulis Theodoulou, Theodoros Mariolis-Sapsakos

    Published 2013-01-01
    “…MYCN is a well-known oncogene overexpressed in different human malignancies including neuroblastoma, rhabdomyosarcoma, medulloblastoma, astrocytoma, Wilms’ tumor, and small cell lung cancer. While neuroblastoma is one of the most common childhood malignancies, in adults it is extremely rare and its treatment is based on pediatric protocols that take into consideration stage and genotypic features, such as MYCN amplification. …”
    Get full text
    Article
  13. 1053

    Financial burden of complications following lung resection: a scoping review protocol by Laurence Weinberg, Stephen Barnett, Jordan Berman, Ariane Flinkier, Fabien Chu, Hugh Slifirski, Rebecca Caragata

    Published 2024-12-01
    “…Respiratory diseases, particularly lung cancer, pose significant public health and economic challenges with thoracic surgery as the standard curative treatment. …”
    Get full text
    Article
  14. 1054

    The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study by Keiichiro Suminaga, Takashi Nomizo, Hironori Yoshida, Hiroaki Ozasa

    Published 2025-02-01
    “…Method Patients treated with immune checkpoint inhibitor monotherapy for non-small cell lung cancer at Kyoto University Hospital until January 2023, with TPS data and biological specimens available for SNP measurement, were eligible for this study. …”
    Get full text
    Article
  15. 1055

    A Case of Cavitary Lung Metastasis From Prostate Cancer by Shinnosuke Ohnaka, Mayumi Aoyama, Rino Arai, Saya Hattori, Yusuke Kubo, Shugo Suzuki, Toshihiro Yoshimura, Akinori Ebihara, Toshiaki Morikawa, Hidenobu Shigemitsu, Ichiro Kuwahira

    Published 2025-01-01
    “…ABSTRACT A 79‐year‐old man was found to have multiple nodules in the lung fields on chest computed tomography. Metastatic lung cancer was suspected; however, the primary site remained elusive. …”
    Get full text
    Article
  16. 1056

    Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer by Salah A. Sheweita, Awad S. Alsamghan

    Published 2020-01-01
    “…Also, intercellular infection of lungs with Chlamydia pneumoniae was found to contribute as one of the ethological factors of lung cancer. Moreover, infection of the urinary tract with Staphylococcus aureus, Klebsiella spp., and Proteus mirabilis has been found to cause bladder cancer. …”
    Get full text
    Article
  17. 1057

    Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets by Hao-Shuai Yang, Jin Zhang, Hong-Xiang Feng, Fei Qi, Fan-Jia Kong, Wei-Jie Zhu, Chao-Yang Liang, Zhen-Rong Zhang

    Published 2025-01-01
    “…BackgroundLung adenocarcinoma (LUAD), the most prevalent form of lung cancer. The transition from adenocarcinoma in situ (AIS), and minimally invasive adenocarcinoma (MIA) to invasive adenocarcinoma (IAC) is not fully understood. …”
    Get full text
    Article
  18. 1058

    The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury by Yongqi Ye, Pengju Zhang, Yuhang Qian, Baoxin Yin, Meijuan Yan

    Published 2017-01-01
    “…Although some studies have confirmed that WISP1 is concerned with colon cancer and lung cancer, there is little report about the influence of WISP1 in traumatic brain injury. …”
    Get full text
    Article
  19. 1059

    Extraction efficiency and bioactive evaluation of Tamarix nilotica and Arthrocnemum macrostachyum extracts for anti-cancer potential. by Maryam Al Kaabi, Nancy A ElNaker, Nila Jan, Michael A Ochsenkühn, Shady A Amin, Lina F Yousef, Ahmed F Yousef

    Published 2025-01-01
    “…Results suggest that: 1) MAE is more efficient than maceration in recovering metabolites from plant biomass based on measurements of total phenolic content, radical scavenging activity, and bioactivity of extracts based on in vitro cytotoxicity. 2) Only T. nilotica extracts were found to be bioactive based on cytotoxicity measurements. 3) Cancer cell lines displayed differential sensitivity to T. nilotica crude extracts, with breast cancer cells being the most sensitive and lung cancer cells being the least sensitive. 4) Solid-phase fractionation of T. nilotica crude extract using different percentages of methanol resulted in several fractions that were 100-fold more cytotoxic compared to the crude unfractionated extract. …”
    Get full text
    Article
  20. 1060

    Somatic Mutaome Profile in Human Cancer Tissues by Nayoung Kim, Yourae Hong, Doyoung Kwon, Sukjoon Yoon

    Published 2013-12-01
    “…The majority of tissue samples harbored 20-80 different mutant genes, on average. Lung cancer samples showed a greater number of mutations in diverse genes than other cancer subtypes. …”
    Get full text
    Article